784
O. D. Lopez et al. / Bioorg. Med. Chem. Lett. 23 (2013) 779–784
15. (a) Itai, A.; Toriumi, Y.; Saito, S.; Kagechika, H.; Shudo, K. J. Am. Chem. Soc. 1992,
References and notes
114, 10649; (b) Yamaguchi, K.; Matsumura, G.; Kagechica, H.; Azumaya, I.; Ito,
Y.; Itai, A.; Shudo, K. J. Am. Chem. Soc. 1991, 113, 5474–5475; (c) Itai, A.;
Toriumi, Y.; Tomioka, N.; Kagechika, H.; Azumaya, I.; Shudo, K. Tetrahedron Lett.
1989, 30, 6177.
1. Paper 2 in the series: St. Laurent, D. R.; Belema, M.; Gao, M.; Goodrich, J.;
Kakarla, R.; Knipe, J. O.; Lemm, J. A.; Liu, M.; Lopez, O. D.; Nguyen, V. N.; Nower,
P. T.; O’Boyle, D., II; Qiu, Y.; Romine, J. L.; Serrano-Wu, M.; Sun, J.-H.; Valera, L.;
Yang, F.; Yang, X.; Meanwell, N. A.; Snyder, L. A. Bioorg. Med. Chem. Lett. 2012,
22, 6063.
2. (a) Alter, M. J. World J. Gastroenterol. 2007, 13, 2436; (b) Davis, G. L.; Alter, M. J.;
El-Serag, H.; Poynard, T.; Jennings, L. W. Gastroenterology 2010, 138, 513.
3. De Francesco, R.; Migliaccio, G. Nature 2005, 436, 953.
16. In the X-ray crystallographic structure of a trans-biphenyl cyclopropane, both
groups are significantly twisted with respect to the plane of the cyclopropyl
ring, exhibiting a torsion angle of ꢁ143° Solorio-Alvarado, C. R.; Wang, Y.;
Echavarren, A. M. J. Am. Chem. Soc. 2011, 133, 11952.
17. The measured solubility (pH = 6.5, phosphate buffer) for 4 was 0.003 mg/mL
while the measured solubility for 9 was 0.135 mg/mL.
18. (a) Ogawa, K.; Sano, T.; Yoshimura, S.; Takeuchi, Y.; Toriumi, K. J. Am. Chem. Soc.
1992, 114, 1041; (b) Harada, J.; Ogawa, K.; Tomoda, S. J. Am. Chem. Soc. 1995,
117, 4476; (c) Kahr, B.; Mitchell, C. A.; Chance, J. M.; Clark, R. V.; Gantzel, P.;
Baldridge, K. K.; Siegel, J. S. J. Am. Chem. Soc. 1995, 117, 4479; (d) Manolov, I.;
Maichle-Moessmer, C. X-ray Struct. Anal. Online 2012, 28, 7.
4. Ishii, S.; Koziel, M. J. Clin. Immunol. 2008, 128, 133.
5. (a) Bartenschlager, R.; Lohmann, V. Antiviral Res. 2001, 52, 1; (b) Lohmann, V.;
Körner, F.; Koch, J. O.; Herian, U.; Theilmann, L.; Bartenschlager, R. Science 1999,
285, 110.
6. Corouge, M.; Pol, S. Med. Mal. Infect. 2011, 41, 579.
7. Lok, A. S.; Gardiner, D. F.; Lawitz, E.; Martorell, C.; Everson, G. T.; Ghalib, R.;
Reindollar, R.; Rustgi, V.; McPhee, F.; Wind-Rotolo, M.; Persson, A.; Zhu, K.;
Dimitrova, D. I.; Eley, T.; Guo, T.; Grasela, D. M.; Pasquinelli, C. N. Engl. J. Med.
2012, 366, 216.
8. (a) Grakoui, A.; McCourt, D. W.; Wychowsky, C.; Feinstone, S. M.; Rice, C. M.
Proc. Natl. Acad. Sci. U.S.A. 1993, 90, 10583; (b) Grakoui, A.; Wychowsky, C.; Lin,
C.; Feinstone, S. M.; Rice, C. M. J. Virol. 1993, 67, 1385.
9. (a) Appel, N.; Pietschmann, T.; Bartenschlager, R. J. Virol. 2005, 79, 3187; (b)
Evans, M. J.; Rice, C. M.; Goff, S. P. Proc. Natl. Acad. Sci. U.S.A. 2004, 101, 13038.
10. (a) Tellinghuisen, T. L.; Marcotrigiano, J.; Rice, C. M. Nature 2005, 435, 374; (b)
Love, R. A.; Brodsky, O.; Hickey, M. J.; Wells, P. A.; Cronin, C. N. J. Virol. 2009, 83,
4395.
19. Schmidbaur, H.; Bublak, W.; Schier, A.; Reber, G.; Müller, G. Chem. Ber. 1988,
121, 1373.
20. (a) Pettit, G. R.; Singh, S. B.; Niven, M. L.; Hamel, E.; Schmidt, J. M. J. Nat. Prod.
1987, 50, 119; (b) Meanwell, N. A.; Romine, J. L.; Rosenfeld, M. J.; Martin, S. W.;
Trehan, A. K.; Wright, J. J. K.; Malley, M. F.; Gougoutas, J. Z.; Brassard, C. L.;
Buchanan, J. O.; Federici, M. E.; Fleming, J. S.; Gamberdella, M.; Hartl, K. S.;
Zavoico, G. B.; Seilert, S. M. J. Med. Chem. 1993, 36, 3884.
21. When the linker was completely removed and the two aryl groups were
directly attached, the genotype 1b EC50 of the resulting analog was 205 nM
suggesting that planarity as well as length might play a role in defining the
pharmacophore.
22. Conformational differences between 29 and 30 were investigated using a
mixed torsional/low mode sampling protocol within Macromodel
[Schrodinger, Maestro v9.2, OPLS2005 FF, water solvent]. An overlay [rmsd
minimized heterocyclic ring] of both structures showed the phenyl ring
adjacent to the methyl substituent in 30 being taken out of co-planarity with a
dihedral angle of 47.0° as compared with 18.5° in the case of 29.
23. (a) Buckler, R. T.; Nichols, G.; Hayao, S.; Hartzler, H. E. U.S. Patent 3,948,929,
1976.; (b) Bredereck, H.; Simchen, G.; Wahl, R. Chem. Ber. 1968, 101, 4048; (c)
Lue, P.; Greenhill, J. V. Adv. Heterocycl. Chem. 1997, 67, 225. and references
therein; (d) Suzuki, H.; Nakaya, C.; Matano, Y. Tetrahedron Lett. 1993, 34, 1055.
11. Lim, P. J.; Chatterji, U.; Cordek, D.; Sharma, S. D.; Garcia-Rivera, J. A.; Cameron,
C. E.; Lin, K.; Targett-Addams, P.; Gallay, P. A. J. Biol. Chem. 2012, 287, 30861.
12. Gao, M.; Nettles, R. E.; Belema, M.; Snyder, L. B.; Nguyen, V. N.; Fridell, R. A.;
Serrano-Wu, M. H.; Langley, D. R.; Sun, J.-H.; O’Boyle, D. R., II; Lemm, J. A.;
Wang, C.; Knipe, J. O.; Chien, C.; Colonno, R. J.; Grasela, D. M.; Meanwell, N. A.;
Hamann, L. G. Nature 2010, 465, 96.
13. Romine, J. L.; St. Laurent, D. R.; Leet, J. E.; Martin, S. W.; Serrano-Wu, M. H.;
Yang, F.; Gao, M.; O’Boyle, D. R., II; Lemm, J. A.; Sun, J.-H.; Nower, P. T.; Huang,
X.; Deshpande, M. S.; Meanwell, N. A.; Snyder, L. B. ACS Med. Chem. Lett. 2011, 2,
224.
14. Even though the cis/trans isomer composition was not monitored during
assaying, the difference in potency observed suggests that an equilibrium state
was not achieved under the assay conditions.